Inari Medical is a medical device company. Co.'s product offerings consist of two minimally-invasive, catheter-based mechanical thrombectomy systems for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, deep vein thrombosis, or DVT, and pulmonary embolism. Co.'s solutions include: ClotTriever System, which is a mechanical thrombectomy system designed to core, capture and remove clots from vessels and is used to treat DVT; FlowTriever System, which is a bore catheter-based aspiration and mechanical thrombectomy system; and ancillary products, which include FlowSaver, FlowStasis, and FlowTriever 2. The NARI stock yearly return is shown above.
The yearly return on the NARI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NARI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|